NeuBase Therapeutics Inc

NASDAQ:NBSE  
1.55
-0.09 (-5.49%)
Earnings Announcements

Neubase Therapeutics Reports Business Update And Financial Results For Fiscal Year 2021

Published: 12/23/2021 21:06 GMT
NeuBase Therapeutics Inc (NBSE) - Neubase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021.
Neubase Therapeutics - Estimates Current Cash and Cash Equivalents Are Sufficient to Fund Currently Planned Operating & Capital Expenditures Into Q1 of Cy2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.